Correlative studies

OTHER14 trials

Sponsors

Ohio State University Comprehensive Cancer Center, Bhuvaneswari Ramaswamy, Pierluigi Porcu, John Hays, Manisha Shah

Conditions

Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaBreast CancerContiguous Stage II Small Lymphocytic LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueHead and Neck CancerHepatocellular Carcinoma

Early Phase 1

Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery

CompletedNCT02013492

William CarsonHepatocellular Carcinoma, Male Breast Cancer, Recurrent Melanoma +5

Start: 2014-01-21End: 2015-06-12Updated: 2022-12-06

Phase 1

Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma

CompletedNCT00561418

Ohio State University Comprehensive Cancer CenterLymphoma, Small Intestine Cancer

Start: 2007-11-30End: 2013-05-31Updated: 2015-07-16

Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma

CompletedNCT01064921

Ohio State University Comprehensive Cancer CenterStage III Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx

Start: 2010-01-19End: 2017-11-08Updated: 2019-06-04

Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

CompletedNCT01129180

Pierluigi PorcuAdult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma +9

Start: 2010-05-31End: 2012-12-31Updated: 2013-12-03

Dabrafenib and Pazopanib Hydrochloride in Treating Patients With Advanced Malignant Tumors

CompletedNCT01713972

Manisha ShahUnspecified Adult Solid Tumor, Protocol Specific

Start: 2012-11-19End: 2018-12-26Updated: 2019-03-01

Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

CompletedNCT02035527

Ohio State University Comprehensive Cancer CenterMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer +34

Start: 2014-04-14End: 2017-04-20Updated: 2018-05-24

Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma

CompletedNCT02049541

Kami Maddocks, MDExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma +6

Start: 2014-07-21End: 2019-04-09Updated: 2022-06-30

Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery

CompletedNCT02120222

Kari KendraRecurrent Melanoma

Start: 2014-08-22End: 2018-04-08Updated: 2023-04-04

Phase 2

Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer

CompletedNCT00201773

Ohio State University Comprehensive Cancer CenterBreast Cancer

Start: 2003-07-31End: 2011-06-30Updated: 2015-06-30

Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer

TerminatedNCT00824733

Bhuvaneswari RamaswamyBreast Cancer

Start: 2009-02-28End: 2014-04-30Updated: 2016-01-14

Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer

CompletedNCT01652196

John HaysMucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Colon +3

Start: 2012-11-14End: 2022-08-30Updated: 2025-02-05

Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL

CompletedNCT02005289

Ohio State University Comprehensive Cancer CenterContiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia +9

Start: 2014-01-17End: 2025-05-20Updated: 2025-12-15

Unknown Phase

Tangerine or Red Tomato Juice in Treating Patients With Prostate Cancer Undergoing Surgery

CompletedNCT02144649

Ohio State University Comprehensive Cancer CenterStage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer +2

Start: 2015-06-30End: 2016-09-22Updated: 2019-08-30

Central Pain Syndrome in Survivors of Head and Neck Cancer

TerminatedNCT04128267

Vanderbilt-Ingram Cancer CenterHead and Neck Cancer

Start: 2019-11-04End: 2022-07-21Updated: 2022-09-19

Related Papers

A phase 2a, single‐arm, open‐label study of tafasitamab, a humanized, Fc‐modified, anti‐CD19 antibody, in patients with relapsed/refractory B‐precursor cell acute lymphoblastic leukemia

Cancer2021-08-0313 citations

Selinexor, a selective inhibitor of nuclear export (SINE), in patients with unresectable melanoma.

Journal of Clinical Oncology2017-05-203 citations

A phase 1 trial of vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced stage head and neck squamous cell carcinoma.

Journal of Clinical Oncology2016-05-201 citations

A phase I/II clinical trial of sorafenib in combination with cisplatin and docetaxel in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN).

Journal of Clinical Oncology2014-05-201 citations

A phase I trial of dabrafenib (BRAF inhibitor) and pazopanib in<i> BRAF-</i>mutated advanced malignancies.

Journal of Clinical Oncology2014-05-201 citations